Bromocriptine Mesylate Tablet
Product Images NDC 0781-5325

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bromocriptine Mesylate (NDC 0781-5325). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image 01

Image 01
The text is a chemical formula: "CagHagBiN:05eCH S0 Mol. wt. 750.72". It includes chemical element symbols and molecular weight. It does not provide enough context to generate a useful description.*
FDA Label Image

Image 02

Image 02
Bromocriptine Mesylate is available in tablet form with a standard dosage of 2.5 mg per tablet. This drug should be stored below 25 degrees Celsius, and it has been defined in the USP. It is important to keep this drug out of the reach of children. This drug is manufactured by Sandoz and supplied in blister packs of 30 tablets each.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.